Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Who benefits from drug discounts? Drugmakers, hospitals battle over indigent-care program.

Lee J.

Mod Healthc. 2013 Jul 15;43(28):8-9. No abstract available.

PMID:
24044228
2.

Pharmaceuticals and medical devices: Medicare Part D. Issue brief.

Steiner DJ.

Issue Brief Health Policy Track Serv. 2012 Dec 31:1-32. No abstract available.

PMID:
23297447
3.

Medicaid payment for generic drugs: achieving savings and access.

Peters CP.

Issue Brief Natl Health Policy Forum. 2010 Sep 30;(839):1-16.

PMID:
20928958
4.

Hospitals cry foul. Preventable readmission penalty brings concerns.

Lubell J.

Mod Healthc. 2010 May 31;40(22):10-1. No abstract available.

PMID:
20540196
5.

Gun to the head. Debt-ceiling law reminds providers who runs the healthcare show.

Burda D.

Mod Healthc. 2011 Aug 8;41(32):21. No abstract available.

PMID:
21879694
6.

CMS retreats on Part D rule intended to reduce drug costs and improve access.

Dickson V.

Mod Healthc. 2014 Mar 17;44(11):10. No abstract available.

PMID:
24830094
7.

340B program presents opportunities--and challenges.

Keough CL, Webster SA.

Healthc Financ Manage. 2009 Nov;63(11):42-4, 46, 48.

PMID:
19891397
8.

Pharmaceuticals and medical devices: Medicare Part D.

Health Policy Tracking Service, a service of Thomson Reuters Accelus., Steiner DJ.

Issue Brief Health Policy Track Serv. 2012 Jan 3:1-37. No abstract available.

PMID:
22403844
9.

Built for the road ahead.

Mansour A.

Healthc Financ Manage. 2015 Oct;69(10):76-81.

PMID:
26595980
10.

Pharmaceuticals and Medical Devices: Medicare Part D.

Steiner DJ; Thomson Reuters Accelus..

Issue Brief Health Policy Track Serv. 2015 Dec 28:1-31. No abstract available.

PMID:
27116795
11.
12.

The Medicare shared savings program.

Desmarais HR.

Bull Am Coll Surg. 2012 Mar;97(3):7-12. No abstract available.

PMID:
22442896
13.

Protect the 340B drug program.

Hart C.

Mod Healthc. 2014 Feb 17;44(7):24. No abstract available.

PMID:
24660395
14.

Healthcare update ... debate over discounted drug prices.

Scott L.

Mod Healthc. 1994 Jun 20;24(25):18. No abstract available.

PMID:
10134465
15.

Pricing data rule revised to 10 years.

Young D.

Am J Health Syst Pharm. 2004 Feb 15;61(4):334, 336. No abstract available.

PMID:
15011759
16.

AIDS patients in Louisiana may lose insurance over anti-kickback laws.

Carlson J.

Mod Healthc. 2014 Feb 24;44(8):10. No abstract available.

PMID:
24730148
17.

New rules for US drug reimbursement.

Bouchie A.

Nat Biotechnol. 2003 Oct;21(10):1119-20. No abstract available.

PMID:
14520382
18.

The need for health care reform.

Mossinghoff GJ.

Health Syst Rev. 1994 May-Jun;27(3):5-6. No abstract available.

PMID:
10134516
19.

Tougher CMS readmissions rules afflict hospitals at a bad time.

Carroll J.

Manag Care. 2011 Sep;20(9):8-11. No abstract available.

20.

Can price and regulatory controls replace free market competition in the drug industry?

Buc NL, Levitt GM.

Healthspan. 1993 Nov;10(10):30-2. No abstract available.

PMID:
10130839
Items per page

Supplemental Content

Support Center